K972414

Substantially Equivalent

FRESHCELLS

Applicant: Diagnostic Hybrids, Inc.
Product code: KIR
Advisory panel: Hematology
Date received: 1997-06-27
Decision date: 1997-08-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Athens, OH, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.